Cargando…

Sepsis and neutropenia in hematological malignancies

Detalles Bibliográficos
Autores principales:	Labiad, Y, Farnault, L, Loriod, B, Costello, R, Nguyen, C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273877/ http://dx.doi.org/10.1186/cc14050

Ejemplares similares

Approaches combining mice and Drosophila melanogaster models to decipher human sepsis
por: Ramy, R, et al.
Publicado: (2014)

Outcome of septic shock in patients with malignancies and neutropenia
por: Furmanchuk, D
Publicado: (2005)

Natural Killer Cells Modulation in Hematological Malignancies
por: Baier, Céline, et al.
Publicado: (2013)

Outcome in severe sepsis and septic shock patients with hematological malignancies: impact of recent intravenous chemotherapeutic treatment
por: Vandijck, D, et al.
Publicado: (2008)

Outcomes of patients with hematologic malignancies admitted to the ICU
por: Duayer, I, et al.
Publicado: (2015)

Is admission of hematologic malignancies in the ICU justified?
por: Gasparovic, VG, et al.
Publicado: (2015)

Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications
por: Farnault, Laure, et al.
Publicado: (2012)

Evaluation of the factors affecting the prognosis of patients with solid tumors and hematologic malignancies in the intensive care unit
por: Savran, Y, et al.
Publicado: (2015)

Targeting hematologic malignancies with oncolytic vaccinia virus constructs
por: Chen, Nanhai, et al.
Publicado: (2013)

Evaluation of automated hematologic VCS parameters in severe sepsis and septic shock: a case-control study
por: Cortegiani, A, et al.
Publicado: (2010)

The contribution of single-cell analysis of acute leukemia in the therapeutic strategy
por: Madaci, Lamia, et al.
Publicado: (2021)

Early risk stratification in patients with oncological and hematological malignancies in the emergency department
por: Rast, A, et al.
Publicado: (2014)

Predictors of poor outcomes in critically ill patients with hematologic malignancy
por: Cornish, M, et al.
Publicado: (2015)

1257. A phase II Prospective Randomized Study to Assess Ceftolozane-Tazobactam in the Management of Febrile Neutropenia in Patients with Hematological Malignancies
por: Chaftari, Anne-Marie, et al.
Publicado: (2020)

Biochemical and hematological parameters (including thromboelastography) differ in patients with sepsis and SIRS after esophagectomy
por: Durila, M, et al.
Publicado: (2011)

P821: LATE ONSET AND/OR LONG LASTING NEUTROPENIA IN CHILDHOOD: CLINICAL AND HEMATOLOGICAL CHARACTERISTICS AND OUTCOMES
por: Kelaidi, C., et al.
Publicado: (2022)

Retrospective study of the outcomes of patients admitted to the ICU with a hematological malignancy
por: Lewis, H, et al.
Publicado: (2012)

Evaluation of risk factors for mortality in hematological malignancy patients admitted to intensive care unit
por: Ileri, I, et al.
Publicado: (2015)

Algorithm for empirical glycopeptide treatment in patients with hematologic malignancies and enterococcus faecium blood stream infection
por: Zhou, X, et al.
Publicado: (2011)

208. Variation in Clinical Practice and Attitudes in the Management of Fever and Neutropenia in Patients With Hematologic Malignancy: A Survey of Cancer Centers Across the United States
por: Aitken, Samuel L, et al.
Publicado: (2020)

Predictors of outcome and severity in adult filipino patients with febrile neutropenia
por: Villalobos, REM, et al.
Publicado: (2015)

Pharmacokinetics and Pharmacodynamics of Cefepime in Adults with Hematological Malignancies and Febrile Neutropenia after Chemotherapy
por: Álvarez, José C., et al.
Publicado: (2021)

Pulmonary Infectious Complications in Children with Hematologic Malignancies and Chemotherapy-Induced Neutropenia
por: Voulgaridou, Aikaterini, et al.
Publicado: (2020)

A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia
por: He, Na, et al.
Publicado: (2020)

Mortality reduction in patients with severe sepsis and septic shock through a comprehensive sepsis initiative
por: Nguyen, K, et al.
Publicado: (2014)

Predictive clinical and hematological factors in the differential diagnosis between malignancy and arthritis in children: a case-control study
por: Trigilia, Cristina, et al.
Publicado: (2011)

An open-label, multicohort Phase Ib trial of pembrolizumab (MK-3475) for advanced hematologic malignancies: KEYNOTE-013
por: Ribrag, Vincent, et al.
Publicado: (2015)

Pharmacokinetics of piperacillin/tazobactam in cancer patients with hematological malignancies and febrile neutropenia after chemotherapy
por: Álvarez, José C, et al.
Publicado: (2013)

Is hyperlactatemia a useful screening marker of severe sepsis in hemato-oncologic malignant patients?
por: Park, S, et al.
Publicado: (2015)

Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update
por: Villafuerte-Gutierrez, Paola, et al.
Publicado: (2014)

A sepsis progression model in humans: characterization of biomarkers descriptive of sepsis progression
por: Footer, BW, et al.
Publicado: (2011)

Clinical and diagnostic significance of apoptosis in the development of neutropenia and bacterial complications in newborns with respiratory distress syndrome
por: Puchtinskaya, M
Publicado: (2012)

Febrile Neutropenia in Hematological Malignancies: Clinical and Microbiological Profile and Outcome in High Risk Patients
por: Lakshmaiah, Kuntegowdanahalli C, et al.
Publicado: (2015)

An epidemiological study of sepsis in ICUs: Sepsis Brazil Study
por: Sales, J, et al.
Publicado: (2006)

Relative adrenal insufficiency in critically ill hematology patients
por: Cerman, J, et al.
Publicado: (2005)

Antibacterial therapy in ovine model of sepsis
por: Nakano, Y, et al.
Publicado: (2006)

Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock
por: Prucha, M, et al.
Publicado: (2005)

Biomarkers of sepsis in burn patients
por: Oueslati, H, et al.
Publicado: (2010)

A novel molecular biomarker diagnostic for the early detection of sepsis
por: Venter, D, et al.
Publicado: (2010)

Fighting hospital sepsis
por: Calini, AR, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nqailqt2c3ctitrfl316b62l1m